- N15, ITTC Building, Plymouth Science Park, 1 Davy Road, Plymouth, PL6 8BX
- +44 1752 764437
- amy.baker@plymouth.ac.uk

Profiles
Dr Amy Baker
Senior Research Fellow in Medical Statistics
Peninsula Medical School (Faculty of Health)
Dr Amy Baker can be contacted through arrangement with our Press Office, to speak to the media on these areas of expertise.
- Applied statistics
Email publicrelations@plymouth.ac.uk to enquire.
Biography
Biography
I am a Senior Research Fellow for the Medical Statistics research group. My primary role is as the lead statistician for the Down's syndrome screening Quality Assurance Support Service.
Qualifications
PhD Statistics (2006)
BSc (Hons) Applied Statistics (2002)
Publications
Publications
Key publications
Key publications are highlighted
Journals
Articles
(2023) 'Enhanced analysis of somatosensory evoked potentials at 20–30 milliseconds can predict neurological outcome after cardiac arrest' Clinical Neurophysiology 153, 141-151 , DOI Open access
(2023) 'Geographical variations in long term colorectal cancer outcomes in England: a contemporary population analysis revealing the north–south divide in colorectal cancer survival' Surgical Endoscopy 37, (7) 5340-5350 , DOI Open access
(2022) 'Young‐onset colorectal cancer: Insights from an English population‐based study' Colorectal Disease , DOI Open access
(2022) 'Colorectal cancer outcomes determined by mode of presentation: analysis of population data in England between 2010 and 2014' Techniques in Coloproctology 26, (5) 363-372 , DOI Open access
(2012) 'Impact of bias in crown-rump length measurement at first-trimester screening for trisomy 21' ULTRASOUND IN OBSTETRICS & GYNECOLOGY 40, (2) 135-139 , DOI
(2011) 'Impact of bias in serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A multiples of the median levels on first-trimester screening for trisomy 21' Ultrasound Obstet Gynecol 38, (3) 309-313 , DOI
(2011) 'BECKMAN COULTER TOTAL HUMAN CHORIONIC GONADOTROPHIN (HCG) AND INHIBIN A IN SECOND TRIMESTER DOWN'S SCREENING USING A QUADRUPLE TEST: A RETROSPECTIVE COMPARISON WITH TRIPLE TESTING' CLINICAL CHEMISTRY AND LABORATORY MEDICINE 49, S709-S709
(2010) 'Cross-trimester repeated measures testing for Down's syndrome screening: an assessment' Health Technol Assess 14, (33) 1-80 , DOI Open access
(2008) 'Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A' Ultrasound Obstet Gynecol 31, (6) 618-624 , DOI
(2007) 'The impact of bias in MoM values on patient risk and screening performance for Down syndrome' Prenatal Diagnosis 27, (9) 840-845
(2006) 'Re: 'Bayesian projections: What are the effects of excluding data from younger age groups'? The authors reply' American Journal of Epidemiology 164, (3) 293-294
(2005) 'Bayesian projections: What are the effects of excluding data from younger age groups?' American Journal of Epidemiology 162, (8) 798-805
Presentations and posters
'Bayesian statistics in the design and analysis of cluster randomised controlled trials and their reporting quality: a methodological systematic review' , DOI Open access